glipizideglyburideglimepiride
… outcome (10%), and incident CKD stages 3–4 (23%) compared with glipizide. However, glyburide was associated with significantly higher ri…
74articles mentioning drugs
385drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Metformin ×
Metformin
This drug is selected. Its supporting articles are shown below.
Articles mentioning Metformin
74 articles · page 3 of 7Metforminoverweight or obesityPubMedoverweight and obesityScopusplacebo
…iginal studies were deemed eligible for this systematic review. Metformin was more effective than placebo in improving Body Mass Index (B…
metformintype 2 diabetesacute coronary syndrome
…and diabetes complications.Results A total of 236 005 adult new metformin users were identified and distributed across the rural-urban co…
metforminGLP1aSGLT2iT2DMtype 2 diabetes mellituscombination therapymonotherapy
…at the diagnosis of T2DM was high. Most prescriptions contained metformin. Monotherapy decreased in 2023–2024 compared with 2018–2022, wh…
MetforminpainWHO International Clinical Trials Registry PlatformClinicalTrials.govCochrane Central Register of Controlled TrialsEMBASE
…ighlighting the need for safer non-opioid treatment strategies. Metformin is a widely prescribed oral antihyperglycaemic agent with emerg…
empagliflozin
…ple with T2DM and established CVD to receive either the SGLT2i, empagliflozin, or placebo.5 To be eligible for this study, people had to meet…
metformingestational diabetes mellitus (GDM)Metabolic dysfunction-associated steatotic liver disease (MASLD)JIPMER Institutional Ethics Committeelifestyle modifications
…nal and fetal health. This study evaluates the effectiveness of metformin, in combination with lifestyle modifications, compared with lif…
MetforminGLP-1 RAAustralian and New Zealand Clinical Trials Registrytype 2 diabetes mellitus (T2D)gestational diabetes mellitus (GDM)physical activity interventionSouth Eastern Sydney Local Health District Human Research Ethics CommitteeT2D
…ul implementation of lifestyle interventions remains a barrier. Metformin is recommended for adults at increased risk of developing T2D; …
metforminbasal insulinGLP-1 RASGLT-2
…pants taking two medications, the most common combinations were metformin with a sulfonylurea (n=31 (27%) in the CGM group and n=21 (36%)…
glipizideSemaglutidesitagliptinempagliflozin
…de (25 936), empagliflozin (715 802), sitagliptin (493 563) and glipizide (832 295) ( online supplemental eTable 1, 5–8). Baseline charac…